 This is a randomized, single-blind, single-center, concurrently controlled, exploratory, Phase I study to determine the in vivo kinetics 24-hour post-infusion recovery and T50 survival of EryDex System EDS -processed autologous red blood cells RBC in non-patient volunteers. A total of 12 non-patient volunteer subjects will be enrolled and assigned to one of the 2 groups 6 subjects in active arm group, 6 subjects in sham arm group. 